Published in Eur J Gastroenterol Hepatol on May 01, 1998
Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut (1999) 2.43
Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiol Mol Biol Rev (1999) 2.13
Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol (2008) 1.84
Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol (2004) 1.42
Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol (2003) 0.95
cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol (1999) 0.86
Relationship between Helicobacter pylori virulence genes and clinical outcomes in Saudi patients. J Korean Med Sci (2012) 0.80
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol (2006) 0.80
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61
Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol (1986) 4.74
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
Campylobacter pyloridis--a new factor in peptic ulcer disease? Gut (1986) 3.26
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89
Lymphocytic gastritis--relationship to Campylobacter pylori infection. J Pathol (1988) 2.88
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43
Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06
Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04
Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol (1986) 2.03
Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03
Dyspepsia: a dilemma for doctors? Lancet (1987) 1.96
Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl (1988) 1.93
Immune response to Campylobacter pyloridis. Lancet (1985) 1.86
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70
How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60
Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57
Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
Persisting "asthma" in tropical pulmonary eosinophilia. Thorax (1983) 1.51
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50
Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49
The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48
Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (Lond) (2007) 1.43
Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42
Campylobacter pyloridis, urease, and gastric ulcers. Lancet (1986) 1.42
Mammography after treatment for breast cancer. BMJ (1994) 1.40
Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39
Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39
Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38
Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32
Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31
Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26
Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20
Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sci (1991) 1.20
Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18
The characterization and pathological significance of gastric Campylobacter-like organisms in the ferret: a model for chronic gastritis? Epidemiol Infect (1988) 1.18
Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin Infect Dis (1995) 1.18
Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med (1983) 1.16
Retracted Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet (1995) 1.11
Comparison of ELISA antigen preparations alone or in combination for serodiagnosing Helicobacter pylori infections. J Clin Pathol (1990) 1.10
Herpesvirus simiae contamination of primary rhesus monkey kidney cell cultures. CDC recommendations to minimize risks to laboratory personnel. Diagn Microbiol Infect Dis (1990) 1.10
Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects. Eye (Lond) (2004) 1.08
Highly potent neurotensin analog that causes hypothermia and antinociception. Eur J Pharmacol (2000) 1.04
Campylobacter pylori and development of duodenal ulcer. Lancet (1988) 1.03
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol (1997) 1.03
Transient monoclonal gammopathy associated with cytomegalovirus infection. Blood (1974) 1.02
Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Summ (1992) 1.02
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
The role of serology in the diagnosis of Campylobacter pylori infection. Scand J Gastroenterol Suppl (1989) 1.02
Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol (2004) 1.02
Immune-complex glomerulonephritis associated with cytomegalovirus infection. Am J Clin Pathol (1979) 1.00
Hemiparasitic plant impacts animal and plant communities across four trophic levels. Ecology (2015) 0.99
Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol (1996) 0.99
Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol (1992) 0.98
The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol (1998) 0.98
The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure. J Glaucoma (1998) 0.98
Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97
B16 murine melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst (1984) 0.97
Nosocomial herpetic infections in a pediatric intensive care unit. Am J Epidemiol (1981) 0.96
The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol (1988) 0.96
Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol (1996) 0.96
A localized stimulation of lens protein synthesis by actinomycin D. Biochim Biophys Acta (1966) 0.95
Cytomegaloviral infection and disease. J Infect Dis (1985) 0.95
Association between BoLA and subclinical bovine leukemia virus infection in a herd of Holstein-Friesian cows. Immunogenetics (1988) 0.95
Provocation-neutralization: a two-part study. Part II. Subcutaneous neutralization therapy: a multi-center study. Otolaryngol Head Neck Surg (1988) 0.95
A comparative trial of desipramine and nortriptyline in depression. Br J Psychiatry (1968) 0.94
Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc Natl Acad Sci U S A (1999) 0.94